$27.49
0.00% day before yesterday
Nasdaq, Sep 26, 03:30 pm CET
ISIN
US82710M1009
Symbol
SILK

Silk Road Medical, Inc. Stock price

$27.49
+0.39 1.44% 1M
+8.78 46.93% 6M
+15.22 124.04% YTD
+12.27 80.62% 1Y
-28.74 51.11% 3Y
-4.16 13.14% 5Y
+7.49 37.45% 10Y
Nasdaq, Closing price Fri, Sep 27 2024
+0.00 0.00%
ISIN
US82710M1009
Symbol
SILK
Sector

Key metrics

Market capitalization $1.12b
Enterprise Value $1.03b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 5.38
P/S ratio (TTM) P/S ratio 5.83
P/B ratio (TTM) P/B ratio 7.22
Revenue growth (TTM) Revenue growth 17.53%
Revenue (TTM) Revenue $191.43m
EBIT (operating result TTM) EBIT $-60.17m
Free Cash Flow (TTM) Free Cash Flow $-36.08m
Cash position $171.98m
EPS (TTM) EPS $-1.44
P/E forward negative
P/S forward 5.48
EV/Sales forward 5.05
Short interest 7.87%
Show more

Is Silk Road Medical, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

Silk Road Medical, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Silk Road Medical, Inc. forecast:

2x Hold
100%

Analyst Opinions

2 Analysts have issued a Silk Road Medical, Inc. forecast:

Hold
100%

Financial data from Silk Road Medical, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
191 191
18% 18%
100%
- Direct Costs 49 49
7% 7%
26%
142 142
21% 21%
74%
- Selling and Administrative Expenses 156 156
22% 22%
81%
- Research and Development Expense 43 43
10% 10%
22%
-56 -56
14% 14%
-29%
- Depreciation and Amortization 3.73 3.73
1% 1%
2%
EBIT (Operating Income) EBIT -60 -60
13% 13%
-31%
Net Profit -57 -57
7% 7%
-30%

In millions USD.

Don't miss a Thing! We will send you all news about Silk Road Medical, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Silk Road Medical, Inc. Stock News

Neutral
PRNewsWire
10 days ago
MARLBOROUGH, Mass. , Sept. 17, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Silk Road Medical, Inc. (Nasdaq: SILK), a medical device company that pioneered a new approach for stroke prevention and the treatment of carotid artery disease through a minimally invasive procedure called transcarotid artery revascularization (TCAR).
Neutral
Accesswire
about one month ago
NEW YORK, NY / ACCESSWIRE / August 22, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Bally's Corporation (NYSE:BALY)'s sale to Standard General L.P. for $18.25 per share.
Neutral
Business Wire
about one month ago
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Silk Road Medical, Inc. (NasdaqGS: SILK) to Boston Scientific Corporation (NYSE: BSX). Under the terms of the proposed transaction, shareholders of Silk Road will receive $27.50 in cash for each share of Silk Road...
More Silk Road Medical, Inc. News

Company Profile

Silk Road Medical, Inc. develops and manufactures medical devices to treat neurovascular diseases. The firm's devices enable vascular access via a puncture adjacent to the collarbone instead of the traditional approach of accessing the vascular system through the groin. Its products include ENROUTE Transcarotid Neuroprotection & Stent System. The company was founded by Tony M. Chou and Michi Garrison on March 21, 2007 and is headquartered in Sunnyvale, CA.

Head office United States
CEO Charles McKhann
Employees 474
Founded 2007
Website www.silkroadmed.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today